Scleroderma pathophysiology

Scleroderma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Scleroderma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Scleroderma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Scleroderma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Scleroderma pathophysiology
CDC on Scleroderma pathophysiology
Scleroderma pathophysiology in the news
Blogs on Scleroderma pathophysiology
Directions to Hospitals Treating Scleroderma
Risk calculators and risk factors for Scleroderma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

Cardiovascular

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

• 
  This is a gross photograph of the heart from this case. There is thickening of the left ventricular wall and some thickening of the right ventricle as well.
• 
  Scleroderma: Right ventricular hypertrophy due to pulmonary fibrosis in Scleroderma
• 
  Scleroderma: Right ventricular hypertrophy due to pulmonary fibrosis in Scleroderma
• 
  Scleroderma: Right ventricular hypertrophy due to pulmonary fibrosis in Scleroderma

References

Template:WikiDoc Sources